Evidence map›Paper›PMID 31069300›Full record

ArticleAPL bioengineering2018

Porous microspheres support mesenchymal progenitor cell ingrowth and stimulate angiogenesis.

Thomas E Paterson, Giulia Gigliobianco, Colin Sherborne, Nicola H Green, James M Dugan, Sheila MacNeil, Gwendolen C Reilly, Frederik Claeyssens

Abstract read
In one paragraph

Article in APL bioengineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Injectable Hydrogel Delivery System with High Drug Loading for Prolonging Local Anesthesia.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thomas E PatersonORCID 0000-0002-2951-115X
Giulia GigliobiancoDepartment of Materials Science and Engineering, Kroto Research Institute, Broad Lane, University of Sheffield, Sheffield S3 7HQ, United Kingdom.
Colin SherborneDepartment of Materials Science and Engineering, Kroto Research Institute, Broad Lane, University of Sheffield, Sheffield S3 7HQ, United Kingdom.
Nicola H Green
James M DuganDepartment of Materials Science and Engineering, Kroto Research Institute, Broad Lane, University of Sheffield, Sheffield S3 7HQ, United Kingdom.
Sheila MacNeilDepartment of Materials Science and Engineering, Kroto Research Institute, Broad Lane, University of Sheffield, Sheffield S3 7HQ, United Kingdom.
Gwendolen C ReillyDepartment of Materials Science and Engineering, Insigneo Institute for in silico Medicine, The University of Sheffield, Sheffield S1 3JD, United Kingdom.
Frederik Claeyssens

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porous microspheres have the potential for use as injectable bone fillers to obviate the need for open surgery. Successful bone fillers must be able to support vascularisation since tissue engineering scaffolds often cease functioning soon after implantation due to a failure to vascularise rapidly. Here, we test the angiogenic potential of a tissue engineered bone filler based on a photocurable acrylate-based high internal phase emulsion (HIPE). Highly porous microspheres were fabricated via two processes, which were compared. One was taken forward and investigated for its ability to support human mesenchymal progenitor cells and angiogenesis in a chorioallantoic membrane (CAM) assay. Porous microspheres with either a narrow or broad size distribution were prepared via a T-junction microfluidic device or by a controlled stirred-tank reactor of the HIPE water in oil in water (w/o/w), respectively. Culture of human embryonic stem cell-derived mesenchymal progenitor (hES-MP) cells showed proliferation over 11 days and formation of cell-microsphere aggregates.

Identifiers

PMID31069300
PMCPMC6481713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.